Dermatology
WHO: Multi-country monkeypox outbreak in non-endemic countries.
23 May, 2022 | 01:46h | UTCMulti-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Commentary on Twitter
The WHO has started to report data on the monkeypox outbreak: https://t.co/e3Q23sllvX pic.twitter.com/3WKqj79eLy
— Max Roser (@MaxCRoser) May 22, 2022
UK, Spain, Portugal report more monkeypox cases.
19 May, 2022 | 11:15h | UTCUK, Spain, Portugal report more monkeypox cases – CIDRAP
See also:
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Commentary on Twitter
On the rare monkeypox outbreak in Europe!
Health officials have little clue where people caught the virus. And there's concern the virus may be spreading through the community – undetected – and possibly through a new route of transmission #IDTwitter https://t.co/KOQ8rM2nW9— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) May 18, 2022
Review: Managing metastatic melanoma in 2022.
19 May, 2022 | 10:23h | UTCManaging Metastatic Melanoma in 2022: A Clinical Review – JCO Oncology Practice
Commentary on Twitter
Managing Metastatic #Melanoma in 2022: Clinical Review
A comprehensive guide to past, present, and future therapeutic approaches for patients with #advancedmelanoma. https://t.co/lh02gmmY27 #melsm #JCOOP @BenSwitzerDO pic.twitter.com/8V4bqcsMGT
— JCO Oncology Practice (@JCOOP_ASCO) February 23, 2022
Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy – A prospective interventional study.
19 May, 2022 | 10:15h | UTC
M-A: Systemic immunomodulatory treatments for atopic dermatitis.
12 May, 2022 | 07:56h | UTCCommentary: Living review compares treatments for atopic dermatitis – HealthDay
Commentary on Twitter:
This systematic review and meta-analysis provides up-to-date comparative evidence of new and old systemic treatments for atopic dermatitis, like biologics and JAK inhibitors. https://t.co/ihqQWlihc7 @aaron_drucker
— JAMA Dermatology (@JAMADerm) March 16, 2022
Guideline: Contact dermatitis.
10 May, 2022 | 10:54h | UTCGerman S1 guideline: Contact dermatitis – Journal of the German Society of Dermatology
Review: Tattoo-related complications in the emergency department.
10 May, 2022 | 10:52h | UTCTattoo-related Complications in the Emergency Department – emDocs
Cohort Study: Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis.
5 May, 2022 | 10:14h | UTCRecurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis – JAMA Dermatology (link to abstract – $ for full-text)
Author Interview: Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
News Release: Patients with rare skin cancer, Merkel cell carcinoma, face 40% recurrence rate – University of Washington School of Medicine
Commentary on Twitter
In this cohort study, Merkel cell carcinoma (MCC) recurrence rate was 40%, more than 90% of MCC recurrences arose within 3 years. https://t.co/46rDnVtyHh
— JAMA Dermatology (@JAMADerm) February 23, 2022
Cohort Study: Spectrum of nonkeratinocyte skin cancer risk among solid organ transplant recipients.
5 May, 2022 | 09:37h | UTCSpectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US – JAMA Dermatology (link to abstract – $ for full-text)
Author Interview: Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients
Commentary on Twitter
This cohort study found elevated incidence for common and rare skin #cancer in solid organ #transplant recipients. Long-term immunosuppression and UV radiation are important risk factors. Treatment with mTOR inhibitors may reduce #melanoma risk. https://t.co/V6Wbbhtyeq
— JAMA Dermatology (@JAMADerm) March 9, 2022
Expert Consensus: Topical treatment of recurrent vulvovaginal candidiasis.
29 Apr, 2022 | 10:46h | UTC
Consensus for the treatment of tinea pedis.
26 Apr, 2022 | 08:02h | UTC
Guidelines: Cutaneous lymphomas.
25 Apr, 2022 | 00:38h | UTC
RCT: Long-term efficacy and safety of up to 108 weeks of Ixekizumab in pediatric patients with moderate to severe plaque psoriasis.
18 Apr, 2022 | 09:49h | UTC
Commentary on Twitter
In this RCT, by 108 weeks of use of ixekizumab for pediatric psoriasis, PASI 75/90/100 were achieved in 92%/79%/55%, respectively, of children, with clearance of nails in 68%, scalp in 76%, genital lesions in 88%, and palm/sole involvement in 90%. https://t.co/vk73Z3MKi4
— JAMA Dermatology (@JAMADerm) April 13, 2022
Review: Cutaneous manifestations of monoclonal gammopathy.
14 Apr, 2022 | 08:21h | UTCCutaneous manifestations of monoclonal gammopathy – Blood Cancer Journal
M-A: Assessment of frequency of rosacea subtypes in patients with rosacea.
13 Apr, 2022 | 09:54h | UTCAssessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis – JAMA Dermatology (link to abstract – $ for full-text)
Commentary: Study Evaluates Prevalence of 4 Major Rosacea Subtypes – HCPLive
Commentary on Twitter
In this systematic review and meta-analysis, erythematotelangiectatic and papulopustular rosacea are the most common subtypes of #rosacea based on global data. https://t.co/2lWCjrIIWP
— JAMA Dermatology (@JAMADerm) April 7, 2022
Global burden of cutaneous melanoma in 2020 and projections to 2040.
31 Mar, 2022 | 08:11h | UTCGlobal Burden of Cutaneous Melanoma in 2020 and Projections to 2040 – JAMA Dermatology (free for a limited period)
Editorial: Melanoma Epidemiology—Pivoting to Low- and Middle-Income Countries (free for a limited period)
Commentary: Global Burden of Melanoma Considerable, Set to Rise by 2040 – HealthDay
RCT: Adalimumab introduction vs. methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis.
29 Mar, 2022 | 08:20h | UTCComparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentary: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis – RheumNow
Commentary on Twitter
https://twitter.com/TheLancetRheum/status/1498245286795390976
RCT: Two phase 3 trials of Baricitinib for Alopecia Areata.
28 Mar, 2022 | 08:49h | UTCTwo Phase 3 Trials of Baricitinib for Alopecia Areata – New England Journal of Medicine
Commentary on Twitter
Alopecia areata is a distressing disorder of hair loss that is mediated partly by cytokines dependent on Janus kinases. The JAK1 and JAK2 inhibitor baricitinib reduced the extent of hair loss in two randomized trials over a period of 36 weeks. #AAD2022 https://t.co/oKKzGF7Q5S pic.twitter.com/gsgWJ1asZN
— NEJM (@NEJM) March 26, 2022
RCT: Hydrosurgical vs. conventional debridement of burns.
28 Mar, 2022 | 08:34h | UTC
Commentary on Twitter
In the April issue of BJS: Hydrosurgical and conventional debridement of burns: randomized clinical trial https://t.co/XoN6w3xkRU @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/YSkczkqnTU
— BJS (@BJSurgery) March 25, 2022
Review | Imaging findings of malignant skin tumors: radiological–pathological correlation.
25 Mar, 2022 | 08:40h | UTC
Estimating overdiagnosis of melanoma using trends among black and white patients in the US.
24 Mar, 2022 | 08:52h | UTCEstimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US – JAMA Dermatology (link to abstract – $ for full-text)
Commentary: Deadly form of skin cancer ‘overdiagnosed’ in some patients, study finds – UPI
Commentary from the author on Twitter (thread – click for more)
The wildest thing about this paper is we wrote it in 2017, then shelved it because of the initial push back in peer review. This experience taught me A LOT about when colleagues are ready to accept ideas that challenge their thinking. 🧵
1/9 https://t.co/hXDURXkwju— Ade Adamson, MD MPP (@AdeAdamson) March 20, 2022
European guidelines on diagnosis and management of mucous membrane pemphigoid.
23 Mar, 2022 | 10:07h | UTC
RCT: Inhibition of Prekallikrein for hereditary angioedema.
23 Mar, 2022 | 10:02h | UTCInhibition of Prekallikrein for Hereditary Angioedema – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
Phase 2 RCT: Prophylactic use of garadacimab in patients with hereditary angioedema.
Evaluation and Management of Angioedema in the Emergency Department
Vitamin B3, niacinamide and reducing skin cancer risk: what does the research say?
22 Mar, 2022 | 08:03h | UTC
Systematic Review: Strategies for using topical corticosteroids in children and adults with eczema.
21 Mar, 2022 | 08:33h | UTCStrategies for using topical corticosteroids in children and adults with eczema – Cochrane Library
Summary: What is the best way to use topical corticosteroids to treat people with eczema? – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1504548242738102273